Teva Pharmaceuticals
TEVA
TEVA
770 hedge funds and large institutions have $24.9B invested in Teva Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 222 increasing their positions, 324 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 727 → 770 (+43)
1.64% more ownership
Funds ownership: 48.15% → 49.78% (+1.6%)
31% less repeat investments, than reductions
Existing positions increased: 222 | Existing positions reduced: 324
Holders
770
Holding in Top 10
58
Calls
$1.28B
Puts
$754M
Top Buyers
| 1 | +$930M | |
| 2 | +$327M | |
| 3 | +$317M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$231M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$181M |
Top Sellers
| 1 | -$683M | |
| 2 | -$267M | |
| 3 | -$251M | |
| 4 |
BTS
BB&T Securities
Richmond,
Virginia
|
-$233M |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$231M |